Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 2.30 +0.04 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.26 | 52 Week High | $ | |||
| Open | $2.26 | 52 Week Low | $ | |||
| Day High | $2.32 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $ | |||
| Volume | 526,699 | |||||
| (NASDAQ: NTRA) | Delayed: 401.37 -12.01 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $413.38 | 52 Week High | $13.80 | |||
| Open | $408.47 | 52 Week Low | $6.52 | |||
| Day High | $416.00 | P/E | N/A | |||
| Day Low | $383.76 | EPS | $0.00 | |||
| Volume | 1,611,806 | |||||



